Histoplasmosis Explained

Histoplasmosis
Synonyms:Cave disease, Darling's disease, Ohio valley disease, Reticuloendotheliosis,[1] Spelunker's lung and Caver's disease
Field:Infectious disease

Histoplasmosis is a fungal infection caused by Histoplasma capsulatum.[2] [3] Symptoms of this infection vary greatly, but the disease affects primarily the lungs.[4] Occasionally, other organs are affected; called disseminated histoplasmosis, it can be fatal if left untreated.

H. capsulatum is found in soil, often associated with decaying bat guano or bird droppings. Disruption of soil from excavation or construction releases infectious spores that can be inhaled by humans. H. capsulatum has a one to two week incubation period within human lungs before symptoms arise.[5] The disease is common among AIDS patients due to their immunosuppression.[6]

From 1938 to 2013 in the US, 105 outbreaks were reported in a total of 26 states plus Puerto Rico. In 1978 to 1979 during a large urban outbreak in which 100,000 people were exposed to the fungus in Indianapolis,[7] victims had pericarditis, rheumatological syndromes, esophageal and vocal cord ulcers, parotitis, adrenal insufficiency, uveitis, fibrosing mediastinitis, interstitial nephritis, intestinal lymphangiectasia, and epididymitis. Histoplasmosis mimics colds, pneumonia, and the flu, and can be shed by bats in their feces.

Signs and symptoms

If symptoms of histoplasmosis infection occur, they start within 3 to 17 days after exposure; the typical time is 12–14 days. Most affected individuals have clinically silent manifestations and show no apparent ill effects. The acute phase of histoplasmosis is characterized by nonspecific respiratory symptoms, often cough or flu-like. Chest X-ray findings are normal in 40–70% of cases.[8] Chronic histoplasmosis cases can resemble tuberculosis;[9] [10] disseminated histoplasmosis affects multiple organ systems and is fatal unless treated.[11]

While histoplasmosis is the most common cause of mediastinitis, this remains a relatively rare disease. Severe infections can cause hepatosplenomegaly, lymphadenopathy, and adrenal enlargement.[4] Lesions often left calcification nodules as they are healed.[12]

Presumed ocular histoplasmosis syndrome causes chorioretinitis, where the choroid and retina of the eyes are scarred, resulting in a loss of vision not unlike macular degeneration. Despite its name, the relationship to Histoplasma is controversial.[13] [14] Distinct from POHS, acute ocular histoplasmosis may rarely occur in immunodeficiency.[15] [16]

Complications

In absence of proper treatment and especially in immunocompromised individuals, complications can arise. These include recurrent pneumonia, respiratory failure, fibrosing mediastinitis, superior vena cava syndrome, pulmonary vessel obstruction, and progressive fibrosis of lymph nodes. Fibrosing mediastinitis is a serious complication and can be fatal. Smokers with structural lung disease have higher probability of developing chronic cavitary histoplasmosis.

After healing of lesions, hard, calcified lymph nodes can erode the walls of the airway, causing hemoptysis.[17]

Mechanisms

H. capsulatum grows in soil and material contaminated with bird or bat droppings (guano). The fungus has been found in poultry-house litter, caves, areas harboring bats, and bird roosts (particularly those of starlings). The fungus is thermally dimorphic; in the environment, it grows as a brownish mycelium, and at body temperature (37 °C in humans), it morphs into a yeast. Histoplasmosis is not contagious but is contracted by inhalation of the spores from disturbed soil or guano.[4] The inoculum is represented principally by microconidia. These are inhaled and reach the alveoli. In the alveoli, macrophages ingest these microconidia. They survive inside the phagosome. As the fungus is thermally dimorphic, these microconidia are transformed into yeast. They grow and multiply inside the phagosome. The macrophages travel in lymphatic circulation and can spread the disease to different organs.[18]

Within the phagosome, the fungus has an absolute requirement for thiamine.[19] Cell-mediated immunity for histoplasmosis develops within 2 weeks. If the patient has strong cellular immunity, macrophages, epithelial cells, and lymphocytes surround the organisms and contain them, and eventually calcify. In immunocompromised individuals, the organisms disseminate to different organs such as bone, spleen, liver, adrenal glands, and mucocutaneous membranes, resulting in progressive disseminated histoplasmosis. Chronic lung disease can manifest.[20]

Diagnosis

Clinically, a wide spectrum of disease manifestations occurs, making diagnosis somewhat difficult. More severe forms include the chronic pulmonary form, often occurring in the presence of underlying pulmonary disease, and a disseminated form, which is characterized by the progressive spread of infection to extrapulmonary sites. Oral manifestations have been reported as the main complaint of the disseminated forms, leading the patient to seek treatment, whereas pulmonary symptoms in disseminated disease may be mild or even misinterpreted as flu.[21] Histoplasmosis can be diagnosed by samples containing the fungus taken from sputum (via bronchoalveolar lavage), blood, or infected organs. It can also be diagnosed by detection of antigens in blood or urine samples by ELISA or polymerase chain reaction. Antigens can cross-react with antigens of African histoplasmosis (caused by Histoplasma duboisii), blastomycosis, coccidioidomycosis, paracoccidioidomycosis, and talaromycosis infection. Histoplasmosis can also be diagnosed by a test for antibodies against Histoplasma in the blood. Histoplasma skin tests indicate whether persons have been exposed, but do not indicate whether they have the disease.[4] Formal histoplasmosis diagnoses are often confirmed only by culturing the fungus directly.[6] Sabouraud agar is one agar growth medium on which the fungus can be cultured. Cutaneous manifestations of disseminated disease are diverse and often present as a nondescript rash with systemic complaints. Diagnosis is best established by urine antigen testing, as blood cultures may take up to 6 weeks for diagnostic growth to occur and serum antigen testing often comes back with a false negative before 4 weeks of disseminated infection.[22]

Types

Histoplasmosis may be divided into these types:[23]

Prevention

Testing or decontaminating most sites that may be contaminated with H. capsulatum is impractical, but the sources below list environments where histoplasmosis is common, and precautions to reduce a person's risk of exposure, in the three parts of the world where the disease is prevalent. Precautions common to all geographical locations would be to avoid accumulations of bird or bat droppings.

The US National Institute for Occupational Safety and Health provides information on work practices and personal protective equipment that may reduce the risk of infection.[24]

A review paper includes information on locations in which Histoplasma has been found in Africa (in chicken runs, on bats, in the caves bats inhabit, and in soil), and a thorough reference list including English, French, and Spanish language references.[25]

Treatment

In the majority of immunocompetent individuals, histoplasmosis resolves without any treatment. Antifungal medications are used to treat severe cases of acute histoplasmosis and all cases of chronic and disseminated disease. Typical treatment of severe disease first involves treatment with amphotericin B, followed by oral itraconazole.[26]

Liposomal preparations of amphotericin B are more effective than deoxycholate preparations. The liposomal preparation is preferred in patients who might be at risk of nephrotoxicity, although all preparations of amphotericin B have risk of nephrotoxicity. Individuals taking amphotericin B are monitored for renal function.[27] Liposomal amphotericin B is better at treating people with progressive disseminated Histoplasmosis and underlying HIV when compared to deoxycholate amphotericin B. Meanwhile, fluconazole performs poorly when compared to other azoles.[28]

Treatment with itraconazole must continue for at least a year in severe cases,[29] while in acute pulmonary Histoplasmosis, 6 to 12 weeks treatment is sufficient. Alternatives to itraconazole are posaconazole, voriconazole, and fluconazole. Individuals taking itraconazole are monitored for hepatic function.

Prognosis

About 90% of patients with normal immune systems regain health without any intervention. Less than 5% need serious treatments.

Epidemiology

H. capsulatum is found throughout the world. It is endemic in certain areas of the United States, particularly in states bordering the Ohio River valley and the lower Mississippi River. The humidity and acidity patterns of soil are associated with endemicity. Bird and bat droppings in soil promote the growth of Histoplasma. Contact with such soil aerosolizes the microconidia, which can infect humans. It is also common in caves in Southern and East Africa. Positive histoplasmin skin tests occur in as many as 90% of the people living in areas where H. capsulatum is common, such as the eastern and central United States.[4]

In Canada, the St. Lawrence River Valley is the site of the most frequent infections, with 20–30% of the population testing positive.[30] A review of reported cases in 2018 showed disease presence throughout Southeast Asia,[31] In India, the Gangetic West Bengal is the site of most frequent infections, with 9.4% of the population testing positive.[32] H. c. capsulatum was isolated from the local soil proving endemicity of histoplasmosis in West Bengal.[33]

In non-endemic countries, 40-50% of histoplasmosis cases are diagnosed in immunocompromised patients (HIV/AIDS, transplanted patients, cancer patients).[34]

Histoplasmosis in Workplaces

H. capsulatum is commonly found across the United States. The fungus can grow in any materials corrupted with bird and bat droppings, but particularly manifests in soils.[35] Histoplasma can present itself as an occupational hazard through causation of the infection Histoplasmosis. Workers in a variety of fields can be exposed to the fungus as spores can be released into the air through any activities which disturb soil.[36] Due to this, occupations at a higher risk for exposure include construction and demolition, landscaping, mining, quarrying, oil and gas extraction, agriculture and forestry industries. Common symptoms in workers are similar to the ones from the exposed general public, such as nonspecific respiratory symptoms like a cough. However, workplace exposures tend to lead to larger outbreaks than non-occupational histoplasmosis, and scientific reviews have shown that occupational histoplasmosis accounts for approximately one third of all documented outbreaks.[37] Though the disease is usually not severe, there have been instances of outbreaks among workers leading to death.[38]

These occurrences emphasize the importance of protective measures for workers. The CDC advises that those who work in potentially hazardous environments reduce their exposure as much as possible following the Hierarchy of hazard controls. They recommend that any build up of bird and bat droppings should be avoided if possible, but if it is unpreventable various engineering, administrative controls and personal protective equipment can be implemented in the workplace.[39] The CDC also suggests that workplaces should be responsible for administrative controls such as developing a safety plan, posting notice of the risk of exposure, disposing of any potentially contaminated materials, and providing proper education on the dangers associated with histoplasma. Adequate personal protective equipment includes a respirator, hooded coveralls, shoe coverings, gloves, and eye protection.

History

Histoplasma was discovered in 1905 by Samuel T. Darling,[40] but only in the 1930s was it discovered to be a widespread infection. Before then, many cases of histoplasmosis were mistakenly attributed to tuberculosis, and patients were mistakenly admitted to tuberculosis sanatoria. Some patients contracted tuberculosis in these sanatoriums.[41]

Society and culture

Notes and References

  1. Book: Rapini . Ronald P. . Bolognia . Jean L. . Jorizzo . Joseph L. . Dermatology: 2-Volume Set . Mosby . St. Louis . 2007 . 978-1-4160-2999-1 .
  2. Book: Johnstone, Ronald B.. Weedon's Skin Pathology Essentials . 2017. Elsevier . 2nd. 978-0-7020-6830-0. 452. 25. Mycoses and Algal infections.
  3. Stenn F . Cave disease or speleonosis . Archives of Internal Medicine . 105 . 2 . 181–3 . February 1960 . 13834312 . 10.1001/archinte.1960.00270140003001 .
  4. Book: Ryan KJ, Ray CG . Sherris Medical Microbiology . limited . 4th . 674–6 . McGraw Hill . 2004 . 978-0-8385-8529-0 .
  5. Book: Pendergast, Mark . Inside the Outbreaks: The Elite Medical Detectives of the Epidemic Intelligence Service . 2010 . . 9780151011209 . 13–14.
  6. Book: Cotran RS, Kumar V, Fausto N, Robbins SL, Abbas AK . Robbins and Cotran Pathologic Basis of Disease . Elsevier/Saunders . St. Louis . 2005 . 754–5 . 978-0-7216-0187-8 .
  7. Web site: Histoplasmosis: A Hoosier Concern. Epidemiology Resource. Center. April 12, 2021. Epidemiology Resource Center.
  8. Web site: Radiology Teaching Files: Case 224856 (Histoplasmosis) . Silberberg P . 2007-03-26 . 2007-07-27 . https://web.archive.org/web/20160303195419/http://www.mypacs.net/cases/HISTOPLASMOSIS-224856.html . 2016-03-03 . dead .
  9. Tong P, Tan WC, Pang M . Sporadic disseminated histoplasmosis simulating miliary tuberculosis . British Medical Journal . 287 . 6395 . 822–3 . September 1983 . 6412842 . 1549119 . 10.1136/bmj.287.6395.822 .
  10. Gari-Toussaint, Marty P, Le Fichoux Y, Loubière R . Histoplasmose d'importation à Histoplasma capsulatum, données biocliniques et thérapeutiques variées, à propos de trois cas observés dans les Alpes maritimes . Bull Soc Fr Mycol Med . 16. 1. 87–90. 1987.
  11. Kauffman CA . Histoplasmosis: a clinical and laboratory update . Clinical Microbiology Reviews . 20 . 1 . 115–32 . January 2007 . 17223625 . 1797635 . 10.1128/CMR.00027-06 .
  12. Disseminated histoplasmosis from a calcified lung nodule after long-term corticosteroid therapy in an elderly Japanese patient: A case report . . Keigo . Kobayashi . Asakura . Takanori . 10.1097/MD.0000000000015264 . 2019 . 17 . Kawada . Ichiro . Hasegawa . Hanako . Chubachi . Shotaro. Ohara . Kentaro . Kuramoto . Junko . Sugiura . Hiroaki . Fujishima . Seitaro . 98 . e15264 . 1536-5964 . 6831385 . 31027078.
  13. Thuruthumaly C, Yee DC, Rao PK . 43761401 . Presumed ocular histoplasmosis . Current Opinion in Ophthalmology . 25 . 6 . 508–12 . November 2014 . 25237930 . 10.1097/ICU.0000000000000100 .
  14. Nielsen JS, Fick TA, Saggau DD, Barnes CH . 25507234 . Intravitreal anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to ocular histoplasmosis syndrome . Retina . 32 . 3 . 468–72 . March 2012 . 21817958 . 10.1097/IAE.0b013e318229b220 .
  15. Macher A, Rodrigues MM, Kaplan W, Pistole MC, McKittrick A, Lawrinson WE, Reichert CM . Disseminated bilateral chorioretinitis due to Histoplasma capsulatum in a patient with the acquired immunodeficiency syndrome . Ophthalmology . 92 . 8 . 1159–64 . August 1985 . 2413418 . 10.1016/s0161-6420(85)33921-0 .
  16. Gonzales CA, Scott IU, Chaudhry NA, Luu KM, Miller D, Murray TG, Davis JL . Endogenous endophthalmitis caused by Histoplasma capsulatum var. capsulatum: a case report and literature review . Ophthalmology . 107 . 4 . 725–9 . April 2000 . 10768335 . 10.1016/s0161-6420(99)00179-7 .
  17. Web site: Hemoptysis. The Lecturio Medical Concept Library . 24 July 2021.
  18. Web site: Histoplasma/Histoplasmosis. The Lecturio Medical Concept Library . 24 July 2021.
  19. Garfoot AL, Zemska O, Rappleye CA (2013) Histoplasma capsulatum depends on de novo vitamin biosynthesis for intraphagosomal proliferation. Infect Immum
  20. Web site: Histoplasmosis. Mayo Clinic . 24 July 2021.
  21. Brazão-Silva MT, Mancusi GW, Bazzoun FV, Ishisaaki GY, Marcucci M. A gingival manifestation of histoplasmosis leading diagnosis. Contemp Clin Dent. V.4 (1). 2013 (http://www.contempclindent.org/text.asp?2013/4/1/97/111621)
  22. Rosenberg JD, Scheinfeld NS . Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome . Cutis . 72 . 6 . 439–45 . December 2003 . 14700213 .
  23. Book: James . William D. . Berger . Timothy G. . Andrews' Diseases of the Skin: clinical Dermatology . Saunders Elsevier . 2006 . 978-0-7216-2921-6 . etal.
  24. NIOSH Publications and Products . Histoplasmosis - Protecting Workers at Risk . DHHS (NIOSH) Publication Number 2005-109 . Centers for Disease Control and Prevention. 13 August 2017. December 2004 . 10.26616/NIOSHPUB2005109.
  25. Gugnani HC, Muotoe-Okafor F . African Histoplasmosis: a review . Revista Iberoamericana de Micologia . 14 . 4 . 155–159 . December 1997 . 15538817 .
  26. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA . Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America . Clinical Infectious Diseases . 45 . 7 . 807–25 . October 2007 . 17806045 . 10.1086/521259 . 7182568 .
  27. Moen MD, Lyseng-Williamson KA, Scott LJ . 34340503 . Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections . Drugs . 69 . 3 . 361–92 . 2009 . 19275278 . 10.2165/00003495-200969030-00010 .
  28. Murray M, Hine P . Treating progressive disseminated Histoplasmosis in people living with HIV . The Cochrane Database of Systematic Reviews . 4 . CD013594 . April 2020 . 4 . 32343003 . 7192368 . 10.1002/14651858.CD013594 . Cochrane Infectious Diseases Group .
  29. Barron MA, Madinger NE. Opportunistic Fungal Infections, Part 3: Cryptococcosis, Histoplasmosis, Coccidioidomycosis, and Emerging Mould Infections. Infections in Medicine. November 18, 2008. July 15, 2009. March 14, 2010. https://web.archive.org/web/20100314111604/http://www.consultantlive.com/infection/article/1145625/1404367. dead.
  30. Web site: Histoplasmosis. . July 1, 2013 . www.ccohs.ca. Canadian Centre for Occupational Health & Safety.
  31. Baker J, Setianingrum F, Wahyuningsih R, Denning DW . Mapping Histoplasmosis in South East Asia - implications for diagnosis in AIDS . Emerging Microbes & Infections . 8 . 1 . 1139–1145 . Jan 2019 . 31364950 . 10.1080/22221751.2019.1644539 . 6711083 . free .
  32. Sanyal M, Thammayya A . Histoplasma capsulatum in the soil of Gangetic Plain in India . The Indian Journal of Medical Research . 63 . 7 . 1020–8 . July 1975 . 1213788 .
  33. Sanyal M, Thammayya A . Skin Sensitivity To Histoplasmin in Calcutta and Its Neighbourhood . Indian Journal of Dermatology, Venereology and Leprology . 46 . 2 . 94–98 . 1980 . 28218139 .
  34. Zerbato . Verena . Di Bella . Stefano . Pol . Riccardo . D'Aleo . Francesco . Angheben . Andrea . Farina . Claudio . Conte . Marco . Luzzaro . Francesco . Lombardi . Gianluigi . Luzzati . Roberto . Principe . Luigi . 2023 . Endemic Systemic Mycoses in Italy: A Systematic Review of Literature and a Practical Update . Mycopathologia . en . 188 . 4 . 307–334 . 10.1007/s11046-023-00735-z . 0301-486X . 10386973 . 37294504.
  35. Web site: Histoplasmosis . 2023-12-04 . medlineplus.gov.
  36. Web site: 2022-08-17 . Histoplasmosis in the Workplace NIOSH CDC . 2023-12-04 . www.cdc.gov . en-us.
  37. de Perio . Marie . Benedict . Kaitlin . Williams . Samantha . Niemeier-Walsh . Christine . Green . Brett J. . Coffey . Christopher . Di Giuseppe . Michelangelo . Toda . Mitsuru . Park . Ju-Hyeong . 26 June 2021 . Occupational Histoplasmosis: Epidemiology and Prevention Measures . Journal of Fungi . 7 . 7 . 510 . 10.3390/jof7070510 . 34206791 . 8306883 . free .
  38. Web site: Armstrong . Paige A . Beard . John D . Bonilla . Luis . 2 December 2018 . Outbreak of Severe Histoplasmosis Among Tunnel Workers . 2023-12-04 .
  39. Web site: HEALTH HAZARDS ASSOCIATED WITH BIRD AND BAT DROPPINGS . 2023-12-04 . www.idph.state.il.us.
  40. Darling ST. A protozoan general infection producing pseudotubercles in the lungs and focal necrosis in the liver, spleen and lymphnodes. J Am Med Assoc. 46. 17. 1283–5. 1906. 10.1001/jama.1906.62510440037003.
  41. Book: Bennett JE, Dolin R, Blaser MJ . Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases . 8th . 11 September 2014 . Elsevier Health Sciences . 978-1-4557-4801-3 .
  42. Web site: Kroll. David. Solving The Mystery Of 'Bamboo Bonfire' Lung Disease. Forbes. 2017-11-04. en. 6 March 2014.
  43. Web site: CNN - Bob Dylan hospitalized with histoplasmosis. https://web.archive.org/web/20071026092311/http://www.cnn.com/SHOWBIZ/9705/28/dylan.ill/. dead. . October 26, 2007.
  44. Web site: Ottier. Morgan. Midwest Fungus, Deadly Disease: A Young Man's Fight For His Life. KWQC. 2022-10-30. en. 3 March 2017.